These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10521108)

  • 1. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection.
    Ashkenazi J; Bar-Hava I; Farhi J; Levy T; Feldberg D; Orvieto R; Ben-Rafael Z
    Fertil Steril; 1999 Oct; 72(4):670-3. PubMed ID: 10521108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
    Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
    Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study.
    Westergaard LG; Erb K; Laursen SB; Rex S; Rasmussen PE
    Fertil Steril; 2001 Sep; 76(3):543-9. PubMed ID: 11532479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization.
    Commenges-Ducos M; Piault S; Papaxanthos A; Ribes C; Dallay D; Commenges D
    Fertil Steril; 2002 Nov; 78(5):1049-54. PubMed ID: 12413992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.
    Selman HA; De Santo M; Sterzik K; Coccia E; El-Danasouri I
    Fertil Steril; 2002 Nov; 78(5):1061-7. PubMed ID: 12413994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles.
    Ou YC; Lan KC; Huang FJ; Kung FT; Lan TH; Chang SY
    Fertil Steril; 2010 Jan; 93(1):96-100. PubMed ID: 19108823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
    Levi-Setti PE; Cavagna M; Bulletti C
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study.
    Mansour R; Tawab N; Kamal O; El-Faissal Y; Serour A; Aboulghar M; Serour G
    Fertil Steril; 2011 Dec; 96(6):1370-1374.e1. PubMed ID: 22047664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of highly purified versus recombinant follicle stimulating hormone on oocyte quality and embryo development in intracytoplasmic sperm injection cycles.
    Murber A; Fancsovits P; Ledó N; Szakács M; Rigó J; Urbancsek J
    Acta Biol Hung; 2011 Sep; 62(3):255-64. PubMed ID: 21840828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial oocyte activation in severe teratozoospermia undergoing intracytoplasmic sperm injection.
    Nasr-Esfahani MH; Razavi S; Javdan Z; Tavalaee M
    Fertil Steril; 2008 Dec; 90(6):2231-7. PubMed ID: 18206146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional in vitro fertilization versus intracytoplasmic sperm injection in patients with borderline semen: a randomized study using sibling oocytes.
    van der Westerlaken L; Naaktgeboren N; Verburg H; Dieben S; Helmerhorst FM
    Fertil Steril; 2006 Feb; 85(2):395-400. PubMed ID: 16595217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.
    European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone
    Fertil Steril; 2002 Sep; 78(3):520-8. PubMed ID: 12215327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.